The new diabetes drug Ozempic, largely used for weight loss, and Wegovy, which is approved for chronic weight management in adults with obesity, have helped thousands of people lose weight, although recent evidence suggests that the medications may have rare but serious side effects.
In addition to common side effects such as nausea, vomiting, and diarrhea, some users have an increased risk of three rare—but very serious—stomach conditions, according to a research letter published on Oct. 5 in the Journal of the American Medical Association.
